Chemical Compound Review:
Arthaxan 4-(6-methoxynaphthalen-2- yl)butan-2-one
Synonyms:
Consolan, Dolsinal, Flambate, Arthraxan, Listran, ...
- Nabumetone therapy of osteoarthritis. A six-week, placebo-controlled study. Blechman, W.J. Am. J. Med. (1987)
- Nabumetone in the treatment of skin and soft tissue injury. Jenner, P.N. Am. J. Med. (1987)
- Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly. Morgan, G.J., Poland, M., DeLapp, R.E. Am. J. Med. (1993)
- Long-term treatment of rheumatoid arthritis comparing nabumetone with aspirin. Bernhard, G.C., Appelrouth, D.J., Bankhurst, A.D., Biundo, J., Bockow, B.I., Brobyn, R.D., Brodsky, A.L., Burch, F.X., Chang, R.W., Cohen, M.H. Am. J. Med. (1987)
- Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis. Eversmeyer, W., Poland, M., DeLapp, R.E., Jensen, C.P. Am. J. Med. (1993)
- Health-related quality-of-life effects of oxaprozin and nabumetone in patients with osteoarthritis of the knee. Zhao, S.Z., Dedhiya, S.D., Bocanegra, T.S., Fort, J.G., Kuss, M.E., Rush, S.M. Clinical therapeutics. (1999)
- A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Elliott, S.N., McKnight, W., Cirino, G., Wallace, J.L. Gastroenterology (1995)
- Rationalizing cyclooxygenase (COX) inhibition for maximal efficacy and minimal adverse events. Freston, J.W. Am. J. Med. (1999)
- Gastrointestinal safety profile of nabumetone: a meta-analysis. Huang, J.Q., Sridhar, S., Hunt, R.H. Am. J. Med. (1999)
- Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Somasundaram, S., Rafi, S., Hayllar, J., Sigthorsson, G., Jacob, M., Price, A.B., Macpherson, A., Mahmod, T., Scott, D., Wrigglesworth, J.M., Bjarnason, I. Gut (1997)
- PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs. DeWitt, D.L., Meade, E.A., Smith, W.L. Am. J. Med. (1993)
- Six-month multi-center study comparing nabumetone with naproxen in the treatment of osteoarthritis. Pisko, E.J., Bockow, B.I., Box, P., Brodsky, A.L., Burch, F.X., Collins, R.L., Fleischmann, R.M., Keller, M.I., Lipani, J.A., Poiley, J.E. Am. J. Med. (1987)
- Randomized trial of low-dose misoprostol and naproxen vs. nabumetone to prevent recurrent upper gastrointestinal haemorrhage in users of non-steroidal anti-inflammatory drugs. Chan, F.K., Sung, J.J., Ching, J.Y., Wu, J.C., Lee, Y.T., Leung, W.K., Hui, Y., Chan, L.Y., Lai, A.C., Chung, S.C. Aliment. Pharmacol. Ther. (2001)
- Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers. Agrawal, N.M., Caldwell, J., Kivitz, A.J., Weaver, A.L., Bocanegra, T.S., Ball, J., Dhadda, S., Hurley, S., Hancock, L. Clinical therapeutics. (1999)
- The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee. Makarowski, W., Weaver, A., Rubin, B., Caldwell, J., McMahon, F.G., Noveck, R.J., Lee, D., Offenberg, H., Sack, M., Sikes, D., Trapp, R., Rush, S., Kuss, M., Ganju, J., Bocanegra, T.S., Ratliff, J.M. Clinical therapeutics. (1996)
- Renal hemodynamic effects of nabumetone, sulindac, and placebo in patients with osteoarthritis. Cangiano, J.L., Figueroa, J., Palmer, R. Clinical therapeutics. (1999)
- Nabumetone pharmacokinetics in patients with varying degrees of renal impairment. Boelaert, J.R., Jonnaert, H.A., Daneels, R.F., Schurgers, M.L., Thawley, A.R., Undre, N.A., Cooper, D.L. Am. J. Med. (1987)
- Nonsteroidal antiinflammatory drug use in patients receiving warfarin: emphasis on nabumetone. Hilleman, D.E., Mohiuddin, S.M., Lucas, B.D. Am. J. Med. (1993)
- Preclinical overview of nabumetone. Pharmacology, bioavailability, metabolism, and toxicology. Mangan, F.R., Flack, J.D., Jackson, D. Am. J. Med. (1987)
- Bioequivalence study of nabumetone: tablet versus suspension. Daigneault, E.A., Ferslew, K.E., Stanton, P. Am. J. Med. (1987)
- Nabumetone kinetics in the young and elderly. McMahon, F.G., Vargas, R., Ryan, J.R., Fitts, D.A. Am. J. Med. (1987)
- Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone. Lussier, A., LeBel, E. Am. J. Med. (1987)
- Nonsteroidal anti-inflammatory drug therapy and gastric side effects. Does nabumetone provide a solution? Dandona, P., Jeremy, J.Y. Drugs (1990)
- Penetration of the active metabolite of nabumetone into synovial fluid and adherent tissue of patients undergoing knee joint surgery. Miehlke, R.K., Schneider, S., Sörgel, F., Muth, P., Henschke, F., Giersch, K.H., Münzel, P. Drugs (1990)
- Evaluation of hydroxyimine as cytochrome P450-selective prodrug structure. Kumpulainen, H., Mähönen, N., Laitinen, M.L., Jaurakkajärvi, M., Raunio, H., Juvonen, R.O., Vepsäläinen, J., Järvinen, T., Rautio, J. J. Med. Chem. (2006)
- Endoscopy-controlled study of the safety of nabumetone compared with naproxen in arthritis therapy. Roth, S.H. Am. J. Med. (1987)
- NSAID gastropathy. The central issue. Roth, S.H. Drugs (1990)
- Interactions of PGH synthase isozymes-1 and -2 with NSAIDs. Smith, W.L., Meade, E.A., DeWitt, D.L. Ann. N. Y. Acad. Sci. (1994)
- Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis. Hedner, T., Samulesson, O., Währborg, P., Wadenvik, H., Ung, K.A., Ekbom, A. Drugs (2004)
- Renal effects of nabumetone, a COX-2 antagonist: impairment of function in isolated perfused rat kidneys contrasts with preserved renal function in vivo. Reichman, J., Cohen, S., Goldfarb, M., Shina, A., Rosen, S., Brezis, M., Karmeli, F., Heyman, S.N. Exp. Nephrol. (2001)
- Safety evaluation of nabumetone in United States clinical trials. Jackson, R.E., Mitchell, F.N., Brindley, D.A. Am. J. Med. (1987)
- Endoscopic studies of nabumetone in patients with rheumatoid arthritis. A comparative endoscopic and histologic evaluation. Greb, W.H., von Schrader, H.W., Cerlek, S., Dominis, M., Hauptmann, E., Zenić, N. Am. J. Med. (1987)
- Population pharmacokinetics of the active metabolite of nabumetone in renal dysfunction. Brier, M.E., Sloan, R.S., Aronoff, G.R. Clin. Pharmacol. Ther. (1995)